Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
•
Hospital Medicine
How often do you check fibrinogen levels and when do you administer FFP for patients with AKI requiring plasma exchange?
Related Questions
What would be your approach to managing severe ANCA-associated vasculitis in a patient who is also septic from a bacterial infection?
Do you modify the albumin level below which you would prophylactically anticoagulate a pregnant patient with nephrotic-range proteinuria, given that hypoalbuminemia is expected in pregnancy?
Do you avoid performing urine microscopy in patients with AKI who have COVID-19 given concern for potential aerosolization?
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Do you recommend fluid restriction in addition to other management strategies for patients with hyponatremia due to SIADH?
What is your approach to managing incidental hypertension without evidence of end-organ damage in hospitalized patients?
Would you start anticoagulation in a previously heathy patient with a new diagnosis of ANCA vasculitis (+PR3, RPGN, crescents on kidney biopsy) who presented with pancreatitis, splenic and renal infarcts and was also found to have CMV viremia?
Do you routinely continue dual antibiotic coverage or de-escalate to monotherapy based on peritoneal fluid culture sensitivities in patients with relapsing pseudomonas aeruginosa peritoneal dialysis peritonitis after peritoneal catheter removal?
Do you recommend plasmapheresis for treatment of patients with osmotic demyelination?
